Researchers at the University of Colorado Anschutz identified a mechanistic link between shingles and lingering post-herpetic neuralgia (PHN), reporting that circulating exosomes can sustain nerve-cell dysfunction after viral clearance. In lab experiments, exosomes collected from PHN patients triggered inflammatory and disease-like changes in healthy nerve cells exposed in vitro. The team described PHN as a “failure-to-resolve” model: rather than the initial varicella zoster virus damage alone, exosome-mediated signaling may keep neurons in an irritated, abnormal remodeling state. The work was published in Annals of Neurology in a paper titled “Circulating Exosomes Drive Persistent Neuronal Dysfunction in Post-Herpetic Neuralgia Patients.” The translational implication is that exosome cargo could become a predictive biomarker and a therapeutic target, shifting PHN research toward extracellular vesicle biology instead of focusing only on viral injury timing. For product developers, the immediate question becomes whether interrupting exosome signaling or cargo loading can prevent or reverse maladaptive neuronal remodeling.